Director Lewis C. Addison filed a Form 4 with the SEC on November 10, 2026, disclosing a purchase of 78 shares of Bank of the James Financial Group Inc common stock on November 9, 2026.
Director Joseph C. Adams of FS Bancorp, Inc. filed a statement of changes in beneficial ownership with the SEC on November 10, 2026, reporting a purchase of common stock on November 6, 2026.
Daewoong Co., Ltd. filed a Form 4 with the SEC on November 10, 2026, disclosing that its affiliate Daewoong Pharmaceutical Co., Ltd. exercised pre-funded warrants covering 11,236,631 shares of AEON Biopharma, Inc. (NASDAQ:AEON) Class A Common Stock on October 30, 2026.
Lockheed Martin issued a press release on November 10, 2026, announcing two production milestones for its GMLRS rocket program, including delivery of the 100,000th rocket and a successful ground test of a new solid rocket motor developed with General Dynamics Ordnance and Tactical Systems.
Mark Earl Hensley, Chief Operating Officer of Heron Therapeutics, Inc. /DE/ (NASDAQ:HRTX), filed a Form 4 on November 10, 2026, reporting changes in beneficial ownership stemming from restricted stock unit activity dated November 6, 2026.
Ronald Todd Plott, a director of Phio Pharmaceuticals Corp., filed a statement of changes in beneficial ownership on November 10, 2026, reporting a purchase of common stock on November 9, 2026.
NextBoat Inc. filed a Form 8-K on November 10, 2026, disclosing via Regulation FD that the company will announce its third quarter 2026 financial and operating results on Monday, November 16, 2026.
Landmark Bancorp, Inc. filed its Form 10-Q quarterly report for the period ended September 30, 2026, with the SEC on November 10, 2026, disclosing financial results for the three and nine months ended September 30, 2026.
Ben Crowl, Chief Lending Officer and Executive Vice President of FS Bancorp, Inc., filed a Form 4 on November 9, 2026, disclosing a transaction in the company's common stock dated November 6, 2026.
Ralph Edward Sorg, Chief Commercial Officer of ArcBest Corp /TX/ (NASDAQ:ARCB), filed a Form 4 on November 10, 2026, disclosing the sale of 6,000 shares of common stock on November 9, 2026.